Vrouwe, J. P. M., Kamerling, I. M. C., vanEsdonk, M. J., Metselaar, J. M., Stuurman, F. E., derPluijm, G. v., . . . Osanto, S. (2021). An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer. Wiley.
Style de citation Chicago (17e éd.)Vrouwe, Josephina P. M., Ingrid M. C. Kamerling, Michiel J. vanEsdonk, Josbert M. Metselaar, Frederik E. Stuurman, Gabri van derPluijm, Jacobus Burggraaf, et Susanne Osanto. An Exploratory First‐in‐man Study to Investigate the Pharmacokinetics and Safety of Liposomal Dexamethasone at a 2‐ and 1‐week Interval in Patients with Metastatic Castration Resistant Prostate Cancer. Wiley, 2021.
Style de citation MLA (8e éd.)Vrouwe, Josephina P. M., et al. An Exploratory First‐in‐man Study to Investigate the Pharmacokinetics and Safety of Liposomal Dexamethasone at a 2‐ and 1‐week Interval in Patients with Metastatic Castration Resistant Prostate Cancer. Wiley, 2021.